Drugs / Interfereon-alfa
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01731158 Background | Oct 2012 → Sep 2016 | renal cell carcinoma | Central European Society for Anticancer Drug Research | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Interfereon-alfa | “Bevacizumab in combination with Interfereon-alfa” NCT01731158 ↗ |